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A B S T R A C T . A 22-year-old woman with recurrent 
goiter, hyperthyroidism, galactorrhea, and amenor-
rhea due to a pituitary tumor is described. She 
had been treated surgically twice for recurrent goiter 
with tracheal compression. Despite clinical signs of 
hyperthyroidism and slightly elevated plasma thyroid 
hormone levels ( T : : 11 /xg/dl; T 3 : 189 ng/dl), without 
thyroid hormone replacement therapy the basal T S H 
level was elevated up to 23 /-tU/ml and could not 
be suppressed by exogenous thyroid hormones: 
even when the serum thyroid hormone levels were 
raised into the thyrotoxic range ( T 4 : 16.2 /u,g/dl T 3 : 
392 ng/dl), the basal T S H fluctuated between 12 and 
29 /xU/ml. T h e basal P R L level was elevated up to 
6000 /LtU/ml. The administration of T R H (200 fxg 
iv) led only to small increments of T S H and P R L 
levels. Bromocriptin (5 mg p.o.) or L-dopa (0.5 g p.o.) 
suppressed T S H and P R L values significantly. After 
transsphenoidal hypophysectomy, T S H and P R L 
were below normal and the patient developed pan-
hypopituitarism. The adenoma showed two cell types 
which could be identified as lactotrophs and thyro-
trophs by electronmicroscopy and immunofluores-
cence. From these data we conclude that the pa-
tient had a pituitary tumor with an overproduction 
of thyrotropin and prolactin, (j Clin Endocrinol 
Metab 43: 137, 1976) 
HY P E R T H Y R O I D I S M due to a thyro-tropin-producing pi tui tary adenoma is 
extremely rare. To our knowledge, there are 
only a few w e l l documented cases i n the 
literature ( 1 , 2 , 3 ) . I n contrast, female patients 
w i t h prolact in-producing tumors and w i t h 
amenorrhea and galactorrhea have been de-
scribed frequently d u r i n g recent years ( 4 , 5 ) . 
We have now observed a patient w i t h recur-
rent proli feration of the thyro id gland, 
hyperthyroidism, galactorrhea, and amenor-
rhea due to the simultaneous hypersecretion 
of T S H and PRL. 
Materials and Methods 
T S H (6), P R L (7), G H , L H , a n d F S H (8) w e r e 
m e a s u r e d by d o u b l e - a n t i b o d y r a d i o i m m u n o a s s a y 
t e c h n i q u e s . T h e reagents for the T S H a n d P R L 
r a d i o i m m u n o a s s a y w e r e o b t a i n e d from the N a -
tional Pi tui tary A g e n c y , Nat ional Inst i tutes of 
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H e a l t h B e t h e s d a , M a r y l a n d , U S A , a n d the N a -
tional Inst i tute for M e d i c a l R e s e a r c h , ( M R C ) , 
L o n d o n . T h y r o t r o p i n a n d P R L w e r e e x p r e s s e d in 
/xU/ml . T w e n t y ^tU of the b P R L research standard 
A-71/222 w e r e e q u i v a l e n t to 1 ng V L S - h P R L 
(7,8). H u m a n growth h o r m o n e a n d L H w e r e 
m e a s u r e d , as d e s c r i b e d p r e v i o u s l y (8), u s i n g our 
o w n ant isera a n d G H (2 I U / m g ) from K a b i C o m p . , 
S w e d e n a n d pituitary L H (2135 I U of 2 n d I R P -
h M G / m g ) as s tandard a n d tracer preparat ion. 
T h e F S H preparat ion h a d a biological act ivity 
of 3 5 0 0 I U 2 n d I R P / m g a n d a r a d i o i m m u n o -
logical act ivi ty of 2330 I U 68/39 M R C a n d was 
o b t a i n e d togedier w i t h a spec i f i c F S H a n t i s e r u m 
from C E A / G i f - s u r - Y v e t t e , F r a n c e . After extrac-
tion from the s e r u m b y m e a n s of chromatog-
r a p h y on s e p h a d e x c o l u m n s i n automat ized 
p r o c e d u r e s , as d e s c r i b e d p r e v i o u s l y , T 3 was de-
t e r m i n e d b y r a d i o i m m u n o a s s a y (9), a n d T 4 (9) 
a n d Cortisol (9,10) b y competitive protein-bind-
i n g a n a l y s i s . T h e T 3 -uptake test was performed 
b y dextran gel filtration (10). 
T h e normal ranges w e r e : T 3 : 8 0 - 1 5 0 ng/dl ; 
T 4 : 4 , 5 - 1 0 / ig /dl ; T 3 - u p t a k e test: 3 2 - 4 2 % ; Basa l 
T S H : < 1 . 0 - 3 . 8 / i U / m l ; Basa l P R L : 1 5 0 - 6 5 0 
/xU/ml ( w o m e n ) . 
Endocrine stimulation and suppression tests 
T R H s t imulat ion test: 200 fig T R H ( H o e c h s t , 
F r a n k f u r t , F R G ) w a s i n j e c t e d iv. L - D o p a s u p p r e s -
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s i o n test: 500 m g L - d o p a ( H o f f m a n n - L a R o c h e 
A G , G r e n z a c h , F R G ) was g i v e n oral ly . B r o m o -
c r i p t i n ( C B - 1 5 4 ) s u p p r e s s i o n test: 5 m g C B - 1 5 4 
( S a n d o z , B a s e l , S w i t z e r l a n d ) was g i v e n orally . 
B l o o d s a m p l e s w e r e taken at di f ferent t imes he-
fore a n d after the adminis t ra t ion of these agents, 
as i n d i c a t e d in F i g . 1 - 3 . T h e T 3 - s up press ion 
test w a s p e r f o n n e d w i t h 100 fig T 3 ( T h y b o n ® , 
H o e c h s t , F r a n k f u r t , F R G ) p e r day oral ly over a 
p e r i o d of 4 w e e k s . L H R H s t imulat ion test: L H 
a n d F S H l e v e l s w e r e d e t e r m i n e d before a n d 
3 0 m i n after the injec t ion of 2 5 fig L H R H intra-
v e n o u s l y ( H o e c h s t , F r a n k f u r t , F R G ) . I n s u l i n hy-
p o g l y c e m i a test: regular i n s u l i n (0.15 U/kg body-
w e i g h t ) w a s i n j e c t e d iv, a n d b l o o d was d r a w n 
before a n d 30, 45, 60, a n d 90 m i n after the i n s u l i n 
i n j e c t i o n . T h e nadir of b l o o d glucose was 35 
mg/dl 4 5 m i n after the i n s u l i n in jec t ion . 
Case report 
I n 1968 a 16-year-old girl n o t i c e d a rapid 
g r o w t h of a goiter w i t h d y s p n e a a n d stridor. I n 
a d d i t i o n , s h e c o m p l a i n e d of w e i g h t loss a n d 
h y p e r p h a g i a , m u s c l e w e a k n e s s , heat in to lerance , 
a n d n e r v o u s n e s s w i t h o u t ophthalmopathy . S i n c e 
the p a t i e n t w a s admit ted to a surgical w a r d of 
a s m a l l hospi ta l no more d e t a i l e d c l i n i c a l records 
a n d no t h y r o i d h o n n o n e l e v e l s of that p e r i o d 
are a v a i l a b l e . A subtotal resec t ion of h e r goiter 
w a s p e r f o n n e d in 1969, m a i n l y b e c a u s e of 
t racheal c o m p r e s s i o n . Postoperat ively , 60 fig T 3 
d a i l y w a s g i v e n , but two years later h y p e r t h y r o i d -
i s m a n d goiter r e c u r r e d . A g a i n , t racheal c o m p r e s -
s i o n l e d to a s e c o n d t h y r o i d resec t ion , this t ime 
c o m b i n e d w i t h a plast ic surgical reconstruct ion of 
a part o f the t r a c h e a b e c a u s e of t r a c h e o m a l a c i a . 
After the s e c o n d operat ion, therapy w i t h 100 
fig T4 a n d 2 0 fig T 3 per day d i d not p r e v e n t the 
r e c u r r e n c e of the goiter. T h e r e f o r e , the patient 
w a s a d m i t t e d to our hospital in 1973 for the first 
t i m e . 
O n a d m i s s i o n , she h a d no complaints con-
c e r n i n g h e r t h y r o i d , but she reported that three 
years ago h e r per iods h a d b e c o m e i r regular a n d 
that o n e y e a r later she o b s e r v e d a m e n o r r h e a . 
S i n c e that t i m e , she h a d also o b s e r v e d galactor-
r h e a from both breasts . 
T h e p h y s i c a l e x a m i n a t i o n r e v e a l e d a di f fusely 
e n l a r g e d t h y r o i d g land. E a c h lobe h a d a s ize of 
a b o u t 4 x 3 c m . T h e r e w e r e no signs of tracheal 
c o m p r e s s i o n b y c l i n i c a l a n d X - r a y e x a m i n a t i o n . 
S h e h a d no c l i n i c a l signs of G r a v e s ' d i s e a s e . 
T h e r e w e r e no v i s u a l field defects . After the 
w i t h d r a w a l of t h y r o i d h o r m o n e therapy for four 
w e e k s , T 4 (11.0 /xg/dl), T 3 (189 ng/dl), a n d 
T 3 res in uptake (41.5%) w e r e s l ight ly e le -
vated . S u r p r i s i n g l y , the basal T S H was 23 /xU/ml, 
but c o u l d not b e further e l e v a t e d by T R H . T h e 
basal P R L l e v e l was 4800 /xU/ml a n d only rose 
to 5400 /xU/ml 30 m i n after T R H . 
Results 
Effect of thyroid hormone administration 
on serum TSH levels 
After four weeks of therapy w i t h 100 /xg 
T 4 and 20 fig T 3 per day, the T 4 level 
was 10.2/xg/dl. The basal T S H level was sti l l 
elevated and showed only a small increase 
from 18 /xU/ml to only 23 /xU/ml 30 m i n after 
T R H injection. Raising the daily dosage of 
t h y r o i d hormones to 150 /xg T 4 and 30 peg 
T 3 for a per iod of 24 days led to an i n -
crease i n the serum T 4 level up to 16.2 /xg/dl, 
but the basal T S H level was persistently 
elevated and resistant to T R H stimulation 
(22.9 and 23.2 /xU/ml, respectively). 
I n order to exclude a disturbance of the 
peripheral conversion of T 4 to T 3 , the pa-
tient was treated w i t h 300 /xg T 4 per day over 
a per iod of 4 weeks. D u r i n g this per iod, 
the T 4 level increased to 17.5 /xg/dl and the 
T 3 uptake test to 63.7%. The basal T S H level 
was sti l l significantly elevated (13.6 /xU/ 
ml) although the conversion of T 4 to T 3 was 
documented by an increase in the T 3 level 
up to 392 ng/dl. Furthermore, f o l l o w i n g 
therapy w i t h 100 /xg T 3 per day over a per iod 
of four weeks, the basal T S H level remained 
elevated (25.6 /xU/ml). The basal PRL level 
was clearly elevated throughout all these 
observations and ranged from 4000 to 6000 
/xU/ml. 
TSH and PRL levels after TRH stimulation 
The T R H stimulation test was performed 
twice, first after a per iod of four weeks 
w i t h o u t exogenous t h y r o i d hormones, and 
second d u r i n g therapy w i t h t h y r o i d hor-
mones (100 /xg T 4 and 20 /xg T 3 p.o. dai ly) . 
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Under both conditions, the T S H and PRL 
levels showed no significant increase after 
T R H inject ion (Fig . 1). 
TSH and PRL levels after L-dopa sup-
pression 
L - D o p a and bromocr ipt in suppression 
tests were done w i t h o u t thyro id hormone 
therapy. 
Both hormones decreased from elevated 
levels to a nadir 120 m i n after the L -dopa 
administrat ion (Fig . 2). When 200 fig T R H 
was injected 60 m i n after L -dopa was given, 
no increase, but a further decline in T S H 
and PRL levels was observed, reaching the 
lowest values 120 m i n after L -dopa (Fig . 2). 
TSH and PRL levels after bromocriptin 
(CB-154) 
F o l l o w i n g 5 m g bromocr ipt in , PRL and 
T S H levels fe l l in a parallel fashion. H o w -
ever, normal values could not be reached 
after this single oral dose (Fig. 3). 
Immunologic characterization of TSH and 
PRL 
I n order to prove the immunological 
ident i ty of the c irculat ing T S H and PRL 
w i t h the respective standard preparations, 
T S H and PRL were estimated in different 
serum di lut ions . The result ing displacement 
curves were parallel w i t h the standard 
curves (not shown). 
Additional clinical studies 
Insul in hypoglycemia induced a rise in 
Cortisol from a normal basal value of 14 
ptg/dl to 31 ju,g/dl, and a rise i n G H from 
2.0 ng/ml to 9 ng/ml 90 m i n after insul in 
injection. After L H R H st imulat ion, L H rose 
from 3.9 to 10.1 ng/ml and FSH from 3.4 
to 8.0 ng/ml. The sella turcica was enlarged; 
pneumencephalography revealed a cisterna 
optochiasmatica of normal size interpreted 
as an intrasellar growth of the tumor w i t h -
out suprasellar extension. The visual fields 
were normal . 
TRH 
200 pg - v 
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-15 0 30 60 90 120 mm 
F I G . 1. Plasma T S H and P R L levels before and after 
T R H stimulation without (closed symboles) and with 
thyroid replacement therapy (open symboles). T h e two 
tests were performed with an interval of four weeks. 
T h e shadowed area represents the response of T S H and 
P R L in normal controls (mean ± 2 S D ) . 
Clinical course 
On A p r i l 22, 1974, a transsphenoidal 
hypophysectomy was performed by curet-
tage combined w i t h a cryoresection of the 
pi tui tary tumor. As shown in F i g . 4, b o t h 
T S H and PRL levels decl ined in parallel 
fashion after the removal of the tumor. Six 
hours after the operation, both hormone 
levels were w i t h i n the normal range. Post-
operatively, the patient had no r a d i o i m -
munoassayable T S H and veiy l o w PRL 
levels i n her serum. A t present, the 
patient receives replacement therapy w i t h 
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F I G . 2. Plasma T S H and P R L 
responses due to L-dopa alone 
(left panel) and to L-dopa and 
subsequent T R H injection (right 
p a n e l ) . The broken lines rep-
resent the upper limit of the 
normal range of the basal values 
for both hormones. 
60 120 180 mm 60 120 180 mm 
A D H , Cortisol, t h y r o i d hormones, and 
gonadal steroids. She has no thyro id enlarge-
ment, has ceased to lactate and is w i t h o u t 
complaints and f u l l y active as a nurse. 
Histology of the pituitary tumor 
The l ight microscopic investigations 1 re-
vealed a pi tui tary adenoma w i t h both acido-
p h i l i c and chromophobe cell, elements. I n 
the electronmicroscopic picture two cell 
types were f o u n d . One showed indented 
nucle i and dense nuc leo l i , the cytoplasm 
was r ich i n rough endoplasmatic re t iculum. 
These cells were indist inguishable from the 
1 actotrophic cells seen i n pregnancy and in 
lactotrophic p i tu i tary tumors. The other cell 
type, w i t h long cell bodies, frequently 
showed secretory phenomena at the cell 
membrane. The granules of these cells, w i t h 
a diameter o f 90 to 200 n m , were smaller 
than those in the lactotrophic cells. These 
cells reacted w i t h an antihuman T S H serum 
by an immunoperoxidase sandwich tech-
n i q u e . 2 Therefore, i t seems l ike ly that these 
cells are T S H - p r o d u c i n g adenoma cells. 
1 We are indebted for these results to Prof. Dr. O. 
Stochdorph, Abt. für Neuropathologie, Patholog. Insti-
tut, University of Munich. 
2 We are indebted for these results to Prof. Dr. 
U . Hachmeister, Zentrum für Pathologie, University 
of Glessen, F R G . 
Discussion 
The present study is, to our knowledge, 
the first report of a patient w i t h a pituitary 
adenoma w i t h simultaneous hypersecretion 
of t h y r o t r o p i n and prolactin. To explain 
this hypersecretion of T S H and PRL, one 
has to consider the possible pathophysi-
ological mechanisms (11-13) : 
a. The concomitant hypersecretion of pro-
lact in and T S H was due to primary hypo-
t h y r o i d i s m . 
b. T h e pi tui tary adenoma produced only 
T S H and i n h i b i t e d by suprasellar extension 
the product ion and/or the portal vessel 
transport of the hypothalamic prolactin-
i n h i b i t i n g factor (PIF) . 
c. The patient had enhanced hypotha-
lamic T R H secretion, w h i c h led to a p i t u i -
tary adenomatous hyperplasia of the thyro-
t roph ic and lactotrophic cells. 
d . Both hormones, T S H and PRL, were 
produced by an "autonomous" pituitary 
adenoma, w h i c h was not suppressed by thy-
r o i d hormones and was not stimulated by 
T R H . 
The first theoretical possibility can be e l im-
inated, since our patient was never hypo-
t h y r o i d . I n addi t ion , the PRL levels i n hypo-
t h y r o i d i s m are only s l ight ly higher and de-
crease towards normal , parallel w i t h the fall 
o f T S H levels d u r i n g t h y r o i d hormone re-
placement therapy (14). I n our patient, 
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F I G . 3. Plasma T S H and P R L 
levels before and after the 
administration of 5 mg C B - 1 5 4 
(bromocriptin). The broken line 
represents the upper limit of the 
normal basal values of both hor-
mones. 
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neither her T S H levels nor the PRL levels 
were lowered to normal by t h y r o i d hor-
mones, even w h e n the peripheral t h y r o i d 
hormone levels were elevated. The develop-
ment of T S H producing tumors as a conse-
quence of long-standing hypothyro id ism 
occurs in the rat (15). Analogous pi tui tary 
adenomas in humans are observed i n areas 
w i t h severe iodine deficiency and endemic 
cretinism (16). 
F I G . 4 . Plasma T S H and P R L 
levels before, during neuro-
surgery, and after transsphe-
noidal resection of the pituitary 
(curettage) and cryohypophx sec-
tomy (cryo). The broken line rep-
.esents the upper limit of the 
normal basal values of both hor-
mones. T h e time in hours is 
shown on the abscissa. 
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I t is d i f f i c u l t to differentiate diffuse hyper-
plasia f rom an adenoma on histological 
grounds. T h e pituitary tumor of our patient 
showed t w o closely associated cell types, 
of w h i c h one could be ident i f ied as a 1 auto-
t r o p h , the other as a TSH-producing cel l . 
Since these t w o different cell types were 
evenly dis t r ibuted i n the adenomatous tis-
sue, i t is un l ike ly that a TSH-producing 
tumor induced the hyperprolactinemia i n 
this case by P I F i n h i b i t i o n . I n addit ion, 
this tumor d i d not show any suprasellar 
extension, and insu l in hypoglycemia i n -
duced a normal rise of Cortisol and h G H i n 
our patient, indicat ing an intact hypotha-
lamic-pi tui tary axis. This does not favor the 
theory of any disturbances in the hypo-
thalamus or i n the pituitary stalk. 
The results of the endocrine tests i n our 
pat ient do not exclude an adenoma due to 
endogenous T R H hypersecretion. However , 
the elevated basal levels of T S H and PRL 
could not be stimulated normally w i t h 
synthetic T R H . Furthermore, the lack of 
suppression of T S H and PRL by t h y r o i d 
hormones suggests an autonomous produc-
t ion o f both hormones by a pi tui tary 
adenoma. 
The pharmacologic suppressors for pro-
lact in, L -dopa and bromocript in caused a 
parallel fall in both hormones. The i n h i b i -
t ion of elevated prolactin levels by bromo-
c r i p t i n occurs at the pituitary level (4). 
Evidence has been accumulated that this 
i n h i b i t i o n is not specific for the lacto-
trophic cells, since i t has been shown 
that both the elevated T S H levels in primary 
hypothyro id i sm (17) and the elevated G H 
levels i n patients w i t h acromegaly can be i n -
h i b i t e d by bromocript in (18). We now 
demonstrate that the hypersecretion of T S H 
by a p i tu i tary tumor can also be i n h i b i t e d 
by this drug. The i n h i b i t i o n of prolactin 
secretion by L -dopa is in part due to the 
s t imulat ion of the hypothalamic P I F (12). 
A n addit ional direct effect of L -dopa on 
p i tu i tary prolactin secretion has also been 
postulated (19). The i n h i b i t i o n of T S H by 
L - d o p a occurs probably at the pituitary 
level , since L -dopa inhibi ts the normal T S H 
response induced by T R H (4,20). Further-
more, a hypothalamic i n h i b i t o r for T S H re-
lease is not k n o w n . F inal ly , the parallel 
decrease in both PRL and T S H in our patient 
suggests that the inh ib i tory effect of these 
drugs occurs at the pi tui tary level for both 
hormones. Thus, the results of the pharma-
cologic studies support the concept of an 
autonomous pituitary adenoma. However, 
the endocrine studies alone cannot rule out 
hypothalamic T R H hypersecretion as a pos-
sible cause for a pi tui tary adenoma. For this 
to be excluded w i t h absolute certainty, 
T R H levels w o u l d have to be measured in 
the portal vessels, w h i c h is not feasible in 
humans. 
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